Discover
BLRX
BioLineRx Ltd.
2.22
1 x 2.20
1 x 2.31
bid
ask
-
0.00
0.18%
1 @ 04:00 PM
2.24 +0.02 (1.08%)
| Ytd | -20.00% | |
| 1y | -46.99% |
2.20
day range
2.27
2.18
52 week range
4.18
| Open | 2.20 | Prev Close | 2.22 | Low | 2.20 | High | 2.27 | Mkt Cap | 11.03M |
| Vol | 9.69K | Avg Vol | 16.39K | EPS | N/A | P/E | N/A | Forward P/E | -1.06 |
| Beta | 0.87 | Short Ratio | 2.39 | Inst. Own | 3.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-23 | 50-d Avg | 2.61 | 200-d Avg | 2.81 | 1yr Est | 4.57 |
| Income Statement | |||
| Total Revenue | 294.00K | ||
| Revenues (USD) | 294.00K | ||
| Cost of Revenue | 59.00K | ||
| Gross Profit | 235.00K | ||
| Operating Expenses | 3.81M | ||
| Research and Development Expense | 2.94M | ||
| Selling, General and Administrative Expense | 865.00K | ||
| Operating Income | -3.57M | ||
| Interest Expense | 208.00K | ||
| Net Income | -4.34M | ||
| Net Income Common Stock | -4.34M | ||
| Net Income Common Stock (USD) | -4.34M | ||
| Consolidated Income | -3.03M | ||
| Net Income to Non-Controlling Interests | 1.31M | ||
| Earning Before Interest & Taxes (EBIT) | -4.13M | ||
| Earning Before Interest & Taxes (USD) | -4.13M | ||
| Weighted Average Shares | 2.66B | ||
| Weighted Average Shares Diluted | 2.66B | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.08M | ||
| Cash and Equivalents (USD) | 13.08M | ||
| Trade and Non-Trade Receivables | 728.00K | ||
| Current Assets | 16.35M | ||
| Property, Plant & Equipment Net | 803.00K | ||
| Total Assets | 33.48M | ||
| Debt Current | 4.76M | ||
| Total Debt | 7.94M | ||
| Current Liabilities | 13.68M | ||
| Debt Non-Current | 3.18M | ||
| Total Liabilities | 16.86M | ||
| Accumulated Retained Earnings (Deficit) | -405.63M | ||
| Accumulated Other Comprehensive Income | -1.42M | ||
| Shareholders Equity | 13.77M | ||
| Shareholders Equity (USD) | 13.77M | ||
| Assets Non-Current | 17.13M | ||
| Total Debt (USD) | 7.94M | ||
| Goodwill and Intangible Assets | 16.33M | ||
| Inventory | 2.17M | ||
| Liabilities Non-Current | 3.18M | ||
| Trade and Non-Trade Payables | 4.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 78.00K | ||
| Net Cash Flow from Financing | -1.14M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.99M | ||
| Capital Expenditure | 6.00K | ||
| Issuance (Purchase) of Equity Shares | 44.00K | ||
| Issuance (Repayment) of Debt Securities | -1.18M | ||
| Net Cash Flow from Investing | 6.35M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.34M | ||
| Net Cash Flow from Operations | -3.22M | ||
| Effect of Exchange Rate Changes on Cash | 132.00K | ||
| Share Based Compensation | 79.00K | ||